nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—ADRA2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00266	0.00266	CbGpPWpGaD
Phentolamine—ADRA1B—AMPK Signaling—TP53—adrenal gland cancer	0.00264	0.00264	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00256	0.00256	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00256	0.00256	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—SPARC—adrenal gland cancer	0.00249	0.00249	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00246	0.00246	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—SDHB—adrenal gland cancer	0.00243	0.00243	CbGpPWpGaD
Phentolamine—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	0.00234	0.00234	CbGpPWpGaD
Phentolamine—ADRA2B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00227	0.00227	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—GNAS—adrenal gland cancer	0.00226	0.00226	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—PRKACA—adrenal gland cancer	0.00225	0.00225	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00224	0.00224	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00222	0.00222	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GNRHR—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Phentolamine—ADRA2C—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—PRKACA—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00205	0.00205	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—SPARC—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.002	0.002	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—TSHR—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00198	0.00198	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—SDHB—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—CDC42—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00187	0.00187	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—IGF2—adrenal gland cancer	0.00184	0.00184	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00183	0.00183	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—GNAS—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—TSHR—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—CDC42—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00174	0.00174	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00173	0.00173	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—IGF2—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—PRKACA—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—GNAS—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00169	0.00169	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00167	0.00167	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00166	0.00166	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00162	0.00162	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—RRM1—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—SDHD—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—POMC—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00147	0.00147	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00147	0.00147	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00142	0.00142	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—POMC—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00134	0.00134	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—RRM1—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—SDHD—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TSHR—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—MED12—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MEN1—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.000999	0.000999	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000993	0.000993	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000985	0.000985	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00098	0.00098	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000978	0.000978	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000977	0.000977	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000974	0.000974	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000962	0.000962	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.000949	0.000949	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000941	0.000941	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000933	0.000933	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000919	0.000919	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000915	0.000915	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000905	0.000905	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000894	0.000894	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000891	0.000891	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000874	0.000874	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000868	0.000868	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000859	0.000859	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000855	0.000855	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	0.000852	0.000852	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000845	0.000845	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000831	0.000831	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000827	0.000827	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000816	0.000816	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000806	0.000806	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000794	0.000794	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	0.00078	0.00078	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000776	0.000776	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000763	0.000763	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000758	0.000758	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000725	0.000725	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000717	0.000717	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000713	0.000713	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000712	0.000712	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000705	0.000705	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000701	0.000701	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000692	0.000692	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000691	0.000691	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000691	0.000691	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000685	0.000685	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.000678	0.000678	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000668	0.000668	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000658	0.000658	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000648	0.000648	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000647	0.000647	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000634	0.000634	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000624	0.000624	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000623	0.000623	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000618	0.000618	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000604	0.000604	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000603	0.000603	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000595	0.000595	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000589	0.000589	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000583	0.000583	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000583	0.000583	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000579	0.000579	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000577	0.000577	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000575	0.000575	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.000575	0.000575	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000573	0.000573	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000568	0.000568	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000563	0.000563	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000561	0.000561	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000554	0.000554	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.00055	0.00055	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000544	0.000544	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000535	0.000535	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000528	0.000528	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000519	0.000519	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000509	0.000509	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000505	0.000505	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.0005	0.0005	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000492	0.000492	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000491	0.000491	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000485	0.000485	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000477	0.000477	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000473	0.000473	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000469	0.000469	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000465	0.000465	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000461	0.000461	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000457	0.000457	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000455	0.000455	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000452	0.000452	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000442	0.000442	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000441	0.000441	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000424	0.000424	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000422	0.000422	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000416	0.000416	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000415	0.000415	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000411	0.000411	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000398	0.000398	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000394	0.000394	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000389	0.000389	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000384	0.000384	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000383	0.000383	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000378	0.000378	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000378	0.000378	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000372	0.000372	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000371	0.000371	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000369	0.000369	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000366	0.000366	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000343	0.000343	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.00034	0.00034	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000336	0.000336	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000329	0.000329	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000325	0.000325	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000316	0.000316	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000312	0.000312	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000302	0.000302	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000301	0.000301	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000297	0.000297	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000277	0.000277	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000273	0.000273	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000261	0.000261	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000243	0.000243	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000235	0.000235	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000225	0.000225	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	0.00022	0.00022	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	0.000219	0.000219	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000216	0.000216	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	0.000198	0.000198	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000192	0.000192	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	0.000185	0.000185	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	0.000182	0.000182	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000179	0.000179	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	0.000161	0.000161	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	0.00015	0.00015	CbGpPWpGaD
